This test evaluates genes associated with Progressive Familial Intrahepatic Cholestasis (PFIC), a group of inherited liver disorders, using advanced Next-Generation Sequencing (NGS). Metropolis Healthcare performs this analysis on an EDTA blood sample to identify mutations that impair bile flow and cause early-onset liver disease. The test supports accurate diagnosis, clinical management, and family counseling. It is especially useful for patients with chronic jaundice, liver dysfunction, or suspected hereditary cholestasis.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0244
Frequently Asked Questions (FAQ's):
What does the PFIC Gene Panel include?
The PFIC panel at Metropolis Healthcare analyzes key genes responsible for hereditary cholestasis to detect disease-causing mutations.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses high-depth NGS technology to sequence multiple genes linked to PFIC with precision and reliability.
Who should take this test?
Individuals with persistent jaundice, pruritus, liver enlargement, or a family history of cholestatic disorders should consider this test at Metropolis Healthcare.
Why is genetic testing important for PFIC?
Genetic insights from Metropolis Healthcare help confirm diagnosis, guide treatment decisions, and assess disease progression risks.
What sample is required for the PFIC panel?
An EDTA blood sample is required, from which Metropolis Healthcare extracts DNA for detailed gene sequencing.
Can this test assist in pediatric diagnosis?
Yes, Metropolis Healthcare frequently performs this panel for infants and children showing early signs of liver dysfunction.
How soon are the results available?
Turnaround times vary depending on analysis complexity, but Metropolis Healthcare ensures timely and comprehensive reports.
Does this test help with family screening and counseling?
Yes, results from Metropolis Healthcare support genetic counseling and risk assessment for family members.